Anika
Therapeutics (NASDAQ:ANIK) will release the fourth quarter earnings for
2007 on March 5.
Anika is
involved in the development, manufacture and commercialization of therapeutic
products to protect, heal and repair tissue.
The hyaluronic acid based products are manufactured and marketing are
made with ORTHOVISC, to treat specific kinds of osteoarthritis. Company products include AMVISC, AMVISC Plus,
STAARVISC-II and ShellGel, HYVISC and INCERT.
ELEVESS is
currently under development.
For more
Earnings related events or to post your own events, visit: